Company Filing History:
Years Active: 2025
Title: Gunjan H Arya: Innovator in RNA-Guided Nucleases
Introduction
Gunjan H Arya is a prominent inventor based in Cary, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA-guided nucleases. With a total of 2 patents, his work is paving the way for advancements in genetic engineering and molecular biology.
Latest Patents
Gunjan H Arya's latest patents focus on RNA-guided nucleases and their active fragments and variants. These patents describe compositions and methods for binding to a target sequence of interest. The compositions are designed for cleaving or modifying a target sequence, visualizing a target sequence, and modifying the expression of a sequence. They include RNA-guided nuclease (RGN) polypeptides, CRISPR RNAs, trans-activating CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding these components. Additionally, the patents provide vectors and host cells that incorporate these nucleic acid molecules, as well as RGN systems for binding to target sequences.
Career Highlights
Gunjan H Arya is currently associated with Lifeedit Therapeutics, Inc., where he continues to innovate in the field of genetic engineering. His work has garnered attention for its potential applications in therapeutic interventions and research.
Collaborations
He collaborates with notable colleagues, including Michael Coyle and Alexandra Briner Crawley, contributing to a dynamic research environment that fosters innovation.
Conclusion
Gunjan H Arya's contributions to RNA-guided nucleases represent a significant advancement in biotechnology. His patents and ongoing work at Lifeedit Therapeutics, Inc. highlight his role as a leading inventor in this transformative field.